丽珠医药 (01513.hk)

+ 收藏

现金流量表(丽珠医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
起始日期 2024-01-012023-01-012023-01-012023-01-012023-01-012022-01-012022-01-012022-01-012022-01-01
截止日期 2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-31
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 123112311231123112311231123112311231
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后上市后上市后
原始币种 人民币人民币人民币人民币人民币人民币人民币人民币人民币
经营活动产生的现金流量
 已付税项(元) -413,140,905.58-1,321,260,953.15-1,021,208,468.12-729,105,258.37-359,227,021.50-1,024,829,347.72-773,543,596.69-462,719,960.20-251,641,887.33
 经营活动产生的现金流量净额其他项目(元) 1,337,389,825.894,570,195,144.953,233,611,823.511,956,410,401.73659,011,615.353,797,500,642.752,621,467,366.441,889,105,773.38961,950,826.29
 经营活动产生的现金流量净额(元) 924,248,920.313,248,934,191.802,212,403,355.391,227,305,143.36299,784,593.852,772,671,295.031,847,923,769.751,426,385,813.18710,308,938.96
投资活动产生的现金流量
 购买物业、厂房及设备支付的现金(元) -155,623,529.66-820,451,640.40-554,644,502.79-399,061,078.37-146,416,939.77-940,146,142.83-790,431,463.53-592,477,259.73-201,222,779.06
 出售物业、厂房及设备收到的现金(元) 201,340.0014,463,408.017,381,053.0153,000.00-2,958,510.89775,169.50580,553.50177,968.00
 购买子公司、联营企业及合营企业支付的现金(元) --22,461,951.59-22,461,951.59-22,461,951.59-12,461,951.59----
 出售子公司、联营企业及合营企业收到的现金(元) -6,000,000.00-------
 购买证券投资所支付的现金(元) -307,748,832.16-502,755,256.73-434,663,606.24-422,646,497.42-8,223,133.14-429,570,006.28-49,756,158.00-40,754,869.06-30,454,493.39
 出售证券投资所收到的现金(元) 5,834,420.64616,831,859.84444,459,112.71401,017,509.4996,275,842.41130,685,851.9964,170,413.7063,808,704.466,832,308.83
 投资活动产生的现金流量净额其他项目(元) --6,000,000.006,000,000.006,000,000.006,202,000.006,190,000.006,190,000.006,160,000.00
 投资活动产生的现金流量净额(元) -457,336,601.18-708,373,580.87-553,929,894.90-437,099,017.89-64,826,182.09-1,229,869,786.23-769,052,038.33-562,652,870.83-218,506,995.62
融资活动产生的现金流量
 新增借款(元) 642,754,935.913,657,570,084.012,731,170,168.701,856,549,701.831,033,525,870.743,713,517,086.473,395,663,680.222,520,437,809.481,676,437,809.48
 偿还借款(元) -1,219,815,571.50-3,125,732,777.68-2,330,352,425.04-1,212,273,289.94-595,574,985.04-2,804,797,777.63-2,594,080,892.47-1,933,795,608.09-1,326,859,803.19
 吸收投资所得(元) 79,098,734.7976,530,000.0039,240,000.0036,790,000.0036,790,000.0042,245,924.9226,581,190.0122,444,277.3721,187,024.40
 已付股息融资(元) -23,816,825.17-1,895,529,762.42-1,843,923,076.72-937,862,237.73-31,165,868.48-1,591,069,562.43-1,566,668,782.30--16,857,731.05
 已付利息融资(元) --------1,454,878,627.93-
 融资活动产生的现金流量净额其他项目(元) -132,834,962.18-369,718,300.73-364,436,517.02-153,095,613.34-126,889,384.84-80,251,634.71-19,084,166.58-11,636,751.78-567,477.57
 融资活动产生的现金流量净额(元) -654,613,688.15-1,656,880,756.82-1,768,301,850.08-409,891,439.18316,685,632.38-720,355,963.38-757,588,971.12-857,428,900.95353,339,822.07
现金及现金等价物净增加额(元) -188,391,565.87903,723,720.72-76,793,532.42412,290,347.56527,826,015.13947,332,713.60453,132,823.4270,402,813.09835,520,113.01
现金及现金等价物的期初余额(元) 10,976,366,402.4410,072,642,681.7210,072,642,681.7210,072,642,681.7210,072,642,681.729,125,309,968.129,125,309,968.129,125,309,968.129,125,309,968.12
汇率变动对现金及现金等价物的影响(元) -690,196.8520,043,866.6133,034,857.1731,975,661.27-23,818,029.01124,887,168.18131,850,063.1264,098,771.69-9,621,652.40
现金及现金等价物的期末余额(元) 10,787,974,836.5710,976,366,402.449,995,849,149.3010,484,933,029.2810,600,468,696.8510,072,642,681.729,578,442,791.549,195,712,781.219,960,830,081.13
公告日期 2024-04-232024-04-292023-10-242023-08-302023-04-202023-04-282022-10-252022-08-172022-04-21
会计准则 大陆会计准则大陆会计准则大陆会计准则大陆会计准则大陆会计准则大陆会计准则大陆会计准则大陆会计准则大陆会计准则
审计意见 ---------
审核师 ---------
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院